PI
Specialization
Focus of research
Clostridium difficilie Infection
Tropical infectious diseases
Immunocompromised travellers/patients and vaccination
Amsterdam Public Health
-
Safety and immunogenicity of a recombinant adenovirus vector-based Ebola vaccine
Grobusch, M. P. & Goorhuis, A., 2017, In: Lancet. 389, 10069, p. 578-580Research output: Contribution to journal › Editorial › Academic › peer-review
-
Zika virus and the risk of imported infection in returned travelers: Implications for clinical care
Goorhuis, A., Von Eije, K. J., Douma, R. A., Rijnberg, N., van Vugt, M., Stijnis, C. & Grobusch, M. P., 2016, In: Travel medicine and infectious disease. 14, 1, p. 13-15Research output: Contribution to journal › Article › Academic › peer-review
-
Zika virus: who's next?
Goorhuis, A. & Grobusch, M. P., 2016, In: Lancet infectious diseases. 16, 11, p. 1204-1205Research output: Contribution to journal › Editorial › Academic › peer-review
- All publications
-
Evaluation of a group-based online informed consent conversation (eConsent) in participants from a low-risk vaccination clinical trial
Tan, N. H., Lafeber, M., Sablerolles, R. S. G., Veerman Roders, I., van de Hoef, A., van Grafhorst, K., Visser, L. G., Postma, D. F., Goorhuis, A., Rietdijk, W. J. R. & van der Kuy, P. H. M., 1 Dec 2024, In: Trials. 25, 1, 528.Research output: Contribution to journal › Article › Academic › peer-review
-
Real-world effectiveness and tolerability of switching to doravirine-based antiretroviral therapy in people with HIV: a nationwide, matched, prospective cohort study
ATHENA National Observational Cohort Study, Sept 2024, In: The Lancet HIV. 11, 9, p. e576-e585Research output: Contribution to journal › Article › Academic › peer-review
-
Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection
COVID Human Genetic Effort, COVIDeF Study Group, French COVID Cohort Study Group, CoV-Contact Cohort, COVID-STORM Clinicians, COVID Clinicians, Orchestra Working Group, Amsterdam UMC Covid-19 Biobank & NIAID-USUHS COVID Study Group, 18 Jul 2024, In: Human Genetics and Genomics Advances. 5, 3, 100300.Research output: Contribution to journal › Article › Academic › peer-review
- All publications